Pre-Eclampsia & Eclampsia Obstetric Nursing

GCC Nursing Clinical Reference — Antepartum, Intrapartum & Postpartum

← All Guides
ⓘ Core Definitions
Pre-Eclampsia

New-onset hypertension ≥140/90 mmHg on two readings ≥4 hours apart, arising after 20 weeks gestation, with either:

  • Proteinuria (PCR ≥30 mg/mmol or ≥300 mg/24hr)
  • Thrombocytopenia (<100,000/μL)
  • Renal insufficiency (creatinine >97 μmol/L)
  • Impaired liver function (AST/ALT >2× upper normal)
  • Pulmonary oedema
  • New-onset headache unresponsive to analgesia
  • Visual disturbance (scotomata, blurring, photopsia)
Eclampsia

Pre-eclampsia + grand mal seizure not attributable to other causes. Can occur:

  • Antepartum (before delivery) — 50%
  • Intrapartum (during labour) — 25%
  • Postpartum (after delivery) — 25% — up to 4 weeks

Key fact: Up to 30% of eclampsia occurs WITHOUT prior hypertension or proteinuria — always suspect in seizures of unknown origin in women of childbearing age.

Severe Features (ANY one qualifies)
  • Systolic BP ≥160 mmHg or diastolic ≥110 mmHg (confirmed ×2, 15 min apart)
  • Thrombocytopenia <100,000/μL
  • Renal insufficiency — creatinine >97 μmol/L (or doubling from baseline)
  • Impaired liver function — AST/ALT >2× upper limit normal
  • Persistent RUQ or epigastric pain unresponsive to analgesia
  • Pulmonary oedema (respiratory compromise)
  • New-onset headache unresponsive to medication
  • Visual disturbance — flashing lights, scotomata, blurred vision
HELLP Syndrome

A severe variant of pre-eclampsia:

  • Haemolysis — microangiopathic haemolytic anaemia, elevated LDH, schistocytes on film
  • ELevated Liver enzymes — AST/ALT raised
  • LP Low Platelets — <100,000/μL

Warning: RUQ pain in pregnancy = URGENT — may signal liver capsule distension or impending rupture.

⚠ Superimposed Pre-Eclampsia on Chronic Hypertension

Women with pre-existing chronic hypertension (before 20 weeks or pre-pregnancy) can develop superimposed pre-eclampsia. Suspect when:

  • Sudden worsening of BP control despite adequate medication
  • New-onset proteinuria or sudden increase in existing proteinuria
  • Thrombocytopenia or elevated liver enzymes newly appearing
  • Symptoms of severe features develop
⚠ GCC-Relevant Risk Factors
High-Prevalence GCC Risks
  • Obesity (BMI >30) — rising rapidly across GCC
  • Type 2 diabetes & insulin resistance
  • Nulliparity
  • Multiple gestation — particularly IVF pregnancies
  • Consanguinity — genetic thrombophilia
  • Late maternal age
General Risk Factors
  • Previous pre-eclampsia (recurrence risk 15–25%)
  • Chronic hypertension
  • Renal disease
  • Thrombophilia (antiphospholipid syndrome)
  • Autoimmune disease (SLE)
  • Family history of pre-eclampsia
Protective / Preventive
  • Aspirin 75–150 mg from 12 weeks in high-risk women
  • Calcium supplementation if low dietary intake
  • Optimise pre-pregnancy BMI and glucose control
  • Adequate antenatal care attendance
  • Prompt BP control
◆ Interactive Severity Assessment Tool

Enter clinical values to generate a classification and urgency recommendation.

Recommended Actions
    This tool is a clinical aid only. Always apply full clinical judgement. Consult obstetric team urgently for any concern.
    📈 Blood Pressure Monitoring Technique
    Correct Technique is Critical — Errors Lead to Under- or Over-diagnosis
    • Patient seated, back supported, feet flat on floor — or left lateral in bed
    • Rest for ≥5 minutes before measurement
    • Cuff size: bladder should encircle ≥80% of arm — use large cuff for arm circumference >33 cm (common in obese patients)
    • Upper arm at heart level; no talking during measurement
    • Use Korotkoff V (disappearance of sound) for diastolic
    • Confirm elevated readings on same arm, 15 minutes apart
    • Automated devices: validate against auscultatory in severe pre-eclampsia — some underread
    Mean Arterial Pressure (MAP)

    MAP = (Systolic + 2×Diastolic) ÷ 3 — useful trend marker; MAP >105 mmHg associated with worse outcomes

    Minimum Frequency — Stable Pre-Eclampsia
    • 4-hourly BP if inpatient
    • Daily self-monitoring if outpatient (home BP)
    • More frequent if >150/100 or symptoms develop
    Frequency — Severe / Deteriorating
    • Continuous monitoring or every 15–30 minutes
    • Arterial line considered in critical cases
    • Document in partogram / obstetric HDU chart
    📌 Proteinuria Assessment
    Spot Urine PCR (Protein:Creatinine Ratio)
    • Preferred rapid method — result in 30–60 minutes
    • PCR ≥30 mg/mmol = significant proteinuria
    • PCR ≥100 mg/mmol = heavy proteinuria
    • First morning void preferred; avoid during UTI

    Dipstick ≥2+ alone: Not sufficient for diagnosis — high false-positive rate. Always confirm with PCR or 24hr collection.

    24-Hour Urine Collection
    • Gold standard — 300 mg/24hr = significant
    • Requires complete collection — educate patient carefully
    • Start collection at 0800 (discard first void), collect all urine for 24hrs
    • Keep refrigerated during collection

    Note: Proteinuria may be absent in up to 20% of pre-eclampsia with severe features — diagnosis based on end-organ involvement alone is valid.

    📋 Maternal Symptom Assessment
    SymptomSignificanceNursing Action
    Headache — frontal or occipital, persistentMay indicate cerebral hypertensive encephalopathy or vasospasm; precedes seizureAssess using pain scale; check BP immediately; document and escalate if unresponsive to paracetamol
    Visual symptoms — flashing lights (photopsia), scotomata, blurring, diplopiaRetinal vasospasm; cerebral involvement — severe featureOphthalmological notation; urgent medical review; dim lighting for comfort
    Epigastric / RUQ painLiver capsule distension from subcapsular haematoma or hepatocellular necrosis; HELLP syndromeURGENT escalation; LFTs + platelets stat; do not dismiss as heartburn
    Nausea & vomitingAssociated with HELLP syndrome and severe liver involvementCheck LFTs; assess for other HELLP signs
    Oedema — face, hands, periorbitalNon-dependent oedema more significant than ankle oedema (common in all pregnancy)Assess daily weight, fluid balance; periorbital oedema = escalate
    Reduced fetal movementFetal compromise secondary to uteroplacental insufficiencyCTG immediately; biophysical profile if CTG abnormal
    🔫 Serial Blood Investigations
    InvestigationFrequencyThreshold / Action
    FBC — Hb, WBC, PlateletsAt presentation; every 24–48hrs if stable; 6–12 hourly if severePlt <100K = HELLP risk; Plt <50K = transfusion threshold; rising haematocrit = haemoconcentration
    LFTs — AST, ALT, bilirubin, LDHEvery 24–48hrsAST/ALT >2× ULN = severe feature; LDH >600 = HELLP haemolysis marker
    Urea & ElectrolytesEvery 24–48hrs; more frequent if oliguricCreatinine >97 μmol/L = renal involvement; rising creatinine = restrict fluid
    Uric acidAt presentation; trend monitoringNot diagnostic; rising trend correlates with severity. >360 μmol/L = monitor closely
    Coagulation — PT, APTT, fibrinogenIf platelets falling; pre-operativelyFibrinogen <2 g/L = concern; DIC developing; required before regional anaesthesia
    Blood filmIf haemolysis suspectedSchistocytes, burr cells = microangiopathic haemolysis — HELLP
    🐾 Fetal Monitoring
    CTG Interpretation Priorities
    • Baseline rate 110–160 bpm = normal
    • Variability ≥5 bpm = reassuring
    • Decelerations: variable (cord) vs late (uteroplacental insufficiency — ominous in pre-eclampsia)
    • Reduced variability or repeated late decelerations = urgent review
    • CTG twice daily minimum in hospitalised pre-eclampsia

    A normal CTG does NOT exclude fetal compromise — combine with liquor volume, Dopplers, and biophysical profile.

    Fetal Growth & Doppler Surveillance
    • Serial growth scans every 2–3 weeks — IUGR occurs in 15–20% of pre-eclampsia
    • Umbilical artery Doppler — raised resistance = placental insufficiency
    • Absent or reversed end-diastolic flow = immediate delivery planning
    • Amniotic fluid index (AFI) — oligohydramnios = chronic fetal compromise
    • Middle cerebral artery (MCA) Doppler — brain sparing pattern
    Biophysical Profile Scoring
    Score 8–10 / 10
    Normal — reassuring, continue monitoring
    Score 6 / 10
    Equivocal — repeat in 6 hours; consider delivery if ≥37 weeks
    Score ≤4 / 10
    Abnormal — urgent delivery planning regardless of gestation
    ✓ Antepartum Assessment Checklist
    ⚠ Treatment Thresholds
    UK / GCC Practice — Treat if Sustained:
    • Systolic ≥150 mmHg, OR
    • Diastolic ≥100 mmHg
    ACUTE Treatment — ACOG / Emergency Threshold:
    • Systolic ≥160 mmHg, OR
    • Diastolic ≥110 mmHg
    • Treat within 30–60 minutes of confirmed reading
    Target BP Range:

    Aim for 140–155 / 90–105 mmHg. Avoid aggressive reduction — rapid BP fall can cause fetal distress via placental hypoperfusion. Do not target normal BP levels.

    💊 First-Line Antihypertensive Agents
    LABETALOL (Alpha & Beta Blocker) — IV First-Line for Acute Severe Hypertension
    IV Bolus Protocol
    • 50 mg IV over 1 minute
    • Repeat at 20-minute intervals PRN
    • Maximum cumulative dose: 200 mg
    • Check BP every 5 minutes after each dose
    IV Infusion (Alternative)
    • 200 mg in 200 mL (1 mg/mL)
    • Start at 20 mg/hr; titrate up
    • Maximum 160 mg/hr
    • Convert to oral when stable
    Oral Dosing (Maintenance)
    • 100–200 mg twice daily; increase as needed to max 800 mg/day
    • Safe in breastfeeding

    Contraindications: Asthma, heart block, uncontrolled heart failure, bradycardia. Monitor for neonatal bradycardia.

    HYDRALAZINE (Vasodilator) — IV Second-Line
    IV Bolus Protocol
    • 5 mg IV bolus over 2–3 minutes
    • Repeat 5–10 mg after 20 minutes if inadequate response
    • Maximum single dose: 10 mg
    Nursing Considerations
    • Monitor BP every 5 minutes post-dose
    • Reflex tachycardia common — document
    • Hypotension risk — have IV fluids ready
    • Headache and flushing — normal side effect
    NIFEDIPINE (Calcium Channel Blocker) — Oral First-Line
    Acute Dosing
    • 10–20 mg immediate release oral — NOT sublingual
    • May repeat after 30 minutes if no response
    • Onset 15–30 minutes
    Maintenance Dosing
    • Modified release (MR): 30–60 mg once daily
    • Safe in breastfeeding
    • Headache common side effect — does NOT indicate treatment failure

    CAUTION — Nifedipine + Magnesium Sulphate: Combination may cause severe hypotension and neuromuscular blockade. Use with extreme caution; monitor BP and reflexes closely if concurrent.

    METHYLDOPA — Oral (Chronic / Maintenance)
    • 250–500 mg three times daily; maximum 3 g/day
    • Long safety record in pregnancy
    • Sedation and dry mouth common
    • NOT for acute severe hypertension — onset too slow
    • Avoid postpartum — associated with postnatal depression
    ✖ Drugs CONTRAINDICATED in Pregnancy Hypertension
    Drug ClassExample AgentsReason Contraindicated
    ACE InhibitorsEnalapril, lisinopril, ramipril, captoprilFetal renal dysgenesis, oligohydramnios, neonatal renal failure, skull ossification defects — avoid all trimesters
    Angiotensin Receptor Blockers (ARBs)Losartan, valsartan, irbesartanSame mechanism of fetal harm as ACEi — CONTRAINDICATED throughout pregnancy
    Direct Renin InhibitorsAliskirenSimilar fetal toxicity to ACEi/ARB
    AtenololAtenololAssociated with IUGR and small-for-gestational-age — avoid if possible; use labetalol instead
    Sublingual NifedipineNifedipine liquid capsule punctured/bittenUncontrolled, precipitous BP drop — fetal distress; not recommended
    ✓ Antihypertensive Management Checklist
    💊 Magnesium Sulphate — Indications & Rationale
    Primary Indication: Eclampsia Treatment

    MgSO4 is the drug of choice for treating and preventing recurrence of eclamptic seizures — superior to diazepam and phenytoin (Magpie Trial evidence).

    Secondary Indication: Seizure Prevention (Prophylaxis)

    Given to women with severe pre-eclampsia features to prevent first seizure. Particularly in GCC hospitals with high-risk populations.

    Mechanism: Competes with calcium at NMDA receptors; reduces cerebral vasospasm; anticonvulsant effect. Also causes peripheral vasodilation — minor antihypertensive effect (NOT a primary antihypertensive).

    💊 Dosing Protocol
    LOADING DOSE

    4 g IV over 20 minutes

    • 4 g = 20 mL of 20% MgSO4, OR 40 mL of 10% MgSO4
    • Diluted in 100 mL Normal Saline or 5% Dextrose
    • Infuse via infusion pump — never bolus
    • Monitor BP and reflexes throughout loading
    MAINTENANCE DOSE

    1–2 g/hr IV infusion

    • Typically 1 g/hr in standard protocol
    • Continue for 24 hours postpartum (or 24hrs post-seizure if eclampsia)
    • Some GCC units continue 48hrs postpartum — check local protocol
    • Use infusion pump; label bag clearly
    Therapeutic Serum Range

    Seizure prophylaxis: 2–3.5 mmol/L  |  Treatment range: 2–4 mmol/L

    Serum Mg levels required if: oliguria, renal impairment, loss of reflexes, or any toxicity concern.

    ⚠ Toxicity Monitoring — NURSING PRIORITY

    Hourly monitoring is mandatory. Escalate and stop infusion if any toxicity sign appears.

    2–3.5 mmol/L
    Therapeutic range — seizure prevention
    4–5 mmol/L
    Loss of patellar reflexes (FIRST sign)
    5–6.5 mmol/L
    Somnolence, slurred speech, diplopia
    >6.5 mmol/L
    Respiratory depression (RR <12)
    >7.5 mmol/L
    Cardiac arrhythmia / arrest risk
    Any sign:
    STOP infusion + give antidote + call team
    Hourly Monitoring Parameters
    ParameterNormal / SafeAction Threshold
    Patellar reflexes (knee jerk)PresentAbsent = STOP infusion immediately — earliest sign of toxicity
    Respiratory rate≥12–16 breaths/minRR <12 = STOP infusion, give antidote, call for help
    Urine output≥25 mL/hr (catheterised)<25 mL/hr for 2 consecutive hours = reduce dose, check serum Mg, fluid review
    Oxygen saturationSpO2 >95%SpO2 <95% = oxygen, assess airway, possible respiratory depression
    Level of consciousnessAlert and orientedDrowsiness, confusion = check serum Mg level urgently
    BPTarget 140–155/90–105Hypotension = check concurrent nifedipine; reduce rate; IV fluid bolus with caution
    ANTIDOTE — Keep at Bedside at ALL Times

    Calcium Gluconate 10% — 10 mL IV over 10 minutes

    • Dose: 1 g (10 mL of 10% calcium gluconate) given slowly IV
    • Repeat if respiratory depression persists
    • Have pre-drawn syringe or ampoule + 10 mL syringe at bedside
    • Do NOT use calcium chloride (risk of tissue necrosis if extravasated)
    • Continue oxygen; support ventilation; call anaesthetics if no improvement
    ⛈ Eclamptic Seizure Management
    EMERGENCY — Follow ABCDE Approach
    Immediate Actions (First 2–3 Minutes)
    • Call for HELP — emergency buzzer / dial hospital emergency
    • Note seizure start time
    • Turn patient to left lateral position — airway, aortocaval decompression
    • Protect from injury — do NOT restrain forcefully
    • Airway: suction if accessible; insert airway if feasible when mouth opens
    • High-flow oxygen 15 L/min via non-rebreathe mask
    • Do NOT give anything oral
    Pharmacological Intervention
    • If NOT on MgSO4: Give loading dose 4 g IV over 20 min
    • If already on MgSO4 and seizure recurs: further 2–4 g IV over 5–10 min
    • If seizure continues >5 minutes or recurs: consider IV diazepam 10 mg or lorazepam 4 mg — anaesthetic team
    • Check serum Mg level post-seizure
    • Ensure bladder catheter in situ — monitor UO

    Postpartum consideration: If seizure occurs in postnatal ward or community — call emergency services, left lateral, MgSO4 if available — transfer to obstetric HDU.

    ✓ Magnesium Protocol Checklist
    ⏰ Timing of Delivery
    Gestation & SituationRecommendationConsiderations
    ≥37 weeks — any pre-eclampsiaRecommend deliveryRisk of deterioration outweighs prematurity risk at term
    ≥34 weeks — severe featuresDeliver after stabilisationSteroids if given time; MgSO4 for neuroprotection <32 weeks
    34–37 weeks — severe featuresDeliver after maternal stabilisationSteroids may be offered; neonatal team involvement
    <34 weeks — severe features, stableSteroids first if feasible (48 hrs); then deliveryBetamethasone 12 mg IM × 2 doses 24hrs apart; may manage conservatively in tertiary centre
    <34 weeks — uncontrolled BP / maternal deteriorationExpedite delivery regardless of gestationMaternal safety takes priority; inform neonatal team
    Eclampsia (any gestation)Stabilise first, then deliverDo not rush to emergency CS during active seizure; stabilise, then plan delivery mode
    🕐 Intrapartum Care
    Monitoring During Labour
    • Continuous electronic fetal monitoring (EFM) — mandatory in pre-eclampsia
    • BP every 15–30 minutes (or continuous arterial line in severe cases)
    • Fluid balance with catheter — hourly urine output
    • MgSO4 infusion continued throughout labour
    • Antihypertensives as required to maintain target BP
    • Anaesthetic team review in advance
    Anaesthesia & Analgesia
    • Epidural anaesthesia is BENEFICIAL in pre-eclampsia — reduces catecholamine surge, lowers BP
    • Ensure platelet count adequate before epidural (>80,000/μL most centres; >100K preferred)
    • Check coagulation if platelets trending down
    • Spinal anaesthesia for CS if platelets adequate
    • General anaesthesia risk: intubation hypertensive response — inform anaesthetist
    Oxytocin Caution

    Oxytocin bolus can cause transient hypotension and tachycardia — use slow infusion titration rather than IV bolus where possible. Standard augmentation protocols apply.

    ERGOMETRINE — CONTRAINDICATED

    Ergometrine (ergot alkaloids) cause severe vasoconstriction and can precipitate catastrophic hypertension — DO NOT use Syntometrine. Use Syntocinon (oxytocin) only for third stage.

    ⚠ Postpartum Pre-Eclampsia — Critical Period
    Pre-eclampsia can WORSEN or first present POSTPARTUM — up to 4 weeks after delivery

    The first 48–72 hours postpartum are the highest risk period for:

    • Eclamptic seizures (25% of all eclampsia is postpartum)
    • Pulmonary oedema — fluid mobilisation from third space
    • HELLP syndrome onset or worsening
    • Hypertensive crisis
    Postnatal Monitoring Requirements
    • BP at least 4-hourly for 24 hours post-delivery
    • Continue MgSO4 for 24 hours postpartum
    • Repeat bloods (FBC, LFTs, U&E) at 24 and 48 hours
    • Strict fluid balance — risk of pulmonary oedema during fluid shift
    • Watch for new symptoms: headache, visual disturbance, epigastric pain
    Postnatal Antihypertensives
    • Continue antihypertensive therapy postnatally
    • Labetalol — safe in breastfeeding; first choice
    • Nifedipine MR — safe in breastfeeding; second choice
    • Avoid methyldopa — associated with postnatal depression
    • ACEi/ARBs still contraindicated if breastfeeding (enalapril is cautiously used in some guidelines — local protocol applies)
    Discharge Criteria & Follow-Up
    CriterionSafe for Discharge
    Blood pressureBP stable <150/100 on oral antihypertensives for ≥24 hours
    BloodsPlatelets rising, LFTs improving, creatinine stable or improving
    SymptomsNo severe symptoms (headache, visual, epigastric resolved)
    Fluid balanceAdequate urine output, no signs of pulmonary oedema
    Home BP planHome BP cuff provided; frequency of monitoring documented
    GP/clinic follow-upAppointment within 5–7 days of discharge; 6-week postnatal check
    Long-term counsellingIncreased lifetime cardiovascular risk explained; future pregnancy planning
    ✓ Delivery & Postpartum Checklist
    🌍 Pre-Eclampsia in the GCC — Epidemiology
    5–8%
    Estimated pre-eclampsia prevalence in GCC pregnancies (vs 2–5% globally)
    Leading
    Pre-eclampsia/eclampsia remains a leading cause of maternal mortality in several GCC countries
    30–40%
    GCC countries with rising obesity rates — major pre-eclampsia risk driver
    Contributing Factors to Higher GCC Rates:
    • High rates of obesity and gestational diabetes
    • High IVF utilisation — multiple gestations
    • Late maternal age at first pregnancy
    • Consanguineous marriages — thrombophilia risk
    • Rapid urbanisation and sedentary lifestyle
    • Vitamin D deficiency (paradoxically high despite sun exposure — clothing practices)
    • Limited antenatal care attendance in some subpopulations
    • Cultural barriers to early presentation
    🏢 Major GCC Obstetric Centres
    Hamad Women's Hospital — Qatar
    • Largest single-site maternity hospital globally
    • >20,000 deliveries per year
    • Dedicated obstetric HDU and ICU
    • MgSO4 protocol per WHO/RCOG guidelines
    Corniche Hospital — Abu Dhabi, UAE
    • Premier obstetric centre in UAE
    • Level III NICU for premature deliveries
    • Pre-eclampsia triage and rapid assessment protocols
    • Joint obstetric/medical multidisciplinary teams
    King Abdulaziz Medical City / KASCH — Saudi Arabia
    • King Abdullah Specialist Children's Hospital
    • Ministry of National Guard — advanced maternal-fetal medicine
    • Training hub for obstetric nurses in Saudi Arabia
    ⚡ HELLP Syndrome — GCC Considerations
    Liver Rupture in HELLP — Rare but Reported in GCC

    Subcapsular liver haematoma and hepatic rupture are life-threatening complications of HELLP syndrome. GCC case reports document this complication, particularly in patients presenting late.

    Warning Signs — Escalate Urgently
    • Severe, worsening RUQ or epigastric pain
    • Sudden onset of diffuse abdominal pain
    • Haemodynamic instability unexplained by other cause
    • Rapidly falling haematocrit
    • CT scan — subcapsular haematoma or free fluid
    Management Principles
    • Urgent obstetric, surgical, and anaesthetic review
    • Massive transfusion protocol
    • Angioembolisation by interventional radiology if available
    • Surgical exploration if rupture
    • Transfer to tertiary centre if needed
    👥 Cultural Considerations in GCC Obstetric Nursing
    Bed Rest — Cultural vs Evidence

    Bed rest for pre-eclampsia is culturally expected and commonly prescribed in some GCC hospitals. Evidence does NOT support bed rest as improving outcomes — and may increase DVT risk. Nurses should educate without dismissing cultural beliefs while following evidence-based protocols.

    Family-Centred Communication

    In GCC culture, family involvement in care decisions is significant. Male family members may be primary communicators. Ensure the patient herself remains central to informed consent while respecting family dynamics. Use professional interpreters — avoid relying on family members for critical medical interpretation.

    Aspirin Prophylaxis Adherence

    Low-dose aspirin (75–150 mg daily from 12 weeks) is underutilised in GCC high-risk patients. Nurse education and midwife-led review clinics can improve adherence. Dispel misconceptions about aspirin harm in pregnancy.

    Postpartum Follow-Up Gaps

    Cultural disengagement from postnatal care is a patient safety risk. Pre-eclampsia can first present or worsen postpartum. Discharge education must be in Arabic with written instructions. Provide emergency contact numbers. Home BP monitoring devices should be issued where possible.

    🎓 GCC Obstetric Nurse Specialist Pathway
    Registration & Pathway
    • Base registration: BSN or equivalent — registered with national nursing council (HAAD/DHA/QCHP/SCFHS/MOH)
    • Maternity nursing experience: minimum 2 years obstetric ward
    • Advanced post-registration: Obstetric/Midwifery diploma or MSc
    • NRP (Neonatal Resuscitation Program) certification
    • CTG interpretation competency sign-off
    • MgSO4 administration competency required in most GCC units
    MgSO4 Protocol Variations Across GCC
    Institution TypeCommon Variation
    Tertiary hospitals (Qatar, UAE)WHO/RCOG standard — 4g load + 1g/hr; 24hr postnatal
    Saudi MOH hospitalsSome use Pritchard regimen (IM + IV combination) in remote settings
    Oman/BahrainIV infusion only; 48hr postnatal in some HELLP cases
    Private sector GCCVariable — check institution-specific protocol
    📚 Key References & Guidelines
    International Guidelines
    • NICE Guideline NG133 — Hypertension in pregnancy (UK)
    • ACOG Practice Bulletin 222 — Gestational Hypertension and Pre-eclampsia (USA)
    • WHO Recommendations — Calcium supplementation & Aspirin prophylaxis
    • Magpie Trial — MgSO4 evidence base
    • ISSHP (International Society for Study of Hypertension in Pregnancy) classification 2018
    GCC Regional References
    • Hamad Medical Corporation (HMC) Clinical Protocols — Qatar
    • Abu Dhabi Health Authority (HAAD) Maternal Health Guidelines
    • Saudi MoH Clinical Practice Guidelines — Hypertension in Pregnancy
    • Gulf Heart Association — Cardiovascular risk in obstetric patients